Transition to KPL-387 Monotherapy Dosing & Administration Study

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Transition to KPL-387 Monotherapy Dosing & Administration Study	Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, cardiovascular disorder, heart disorder, pericarditis	Recruiting	Phase 2	2026-09-30		NCT07288216

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Kiniksa Pharmaceuticals International, plc	3
Kiniksa Pharmaceuticals, GmbH	2

0 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
No products are listed yet.

Clinical trials